Gasang, Harlene I.

HRN: 22-28-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CEFUROXIME 1.5GM (VIAL)
12/26/2022
12/26/2022
IVT
1.5g
LD
Preop Prophylaxis
Waiting Final Action 
12/26/2022
CEFUROXIME 1.5GM (VIAL)
12/26/2022
12/27/2022
IVT
1.5g
Q8 X 2 Doses
S/P LTCS
Waiting Final Action 
12/27/2022
CEFUROXIME 500MG (TAB)
12/27/2022
01/02/2023
PO
500
Bid
Repeat LSCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: